NCT04414722View on ClinicalTrials.gov

Mechanisms of Probiotics and Antibiotic-Associated Diarrhea

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Antibiotic-associated Diarrhea
Interventions
DRUG

Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet

Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet

BIOLOGICAL

BB-12

Bifidobacterium animalis subsp. lactis BB-12 (BB-12)-supplemented yogurt

OTHER

Control Yogurt

Yogurt without Bifidobacterium animalis subsp. lactis BB-12 (BB-12)

Trial Locations (1)

20007

Georgetown University Department of Family Medicine, Washington D.C.

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

University of Maryland, Baltimore

OTHER

collaborator

Penn State University

OTHER

lead

Georgetown University

OTHER

NCT04414722 - Mechanisms of Probiotics and Antibiotic-Associated Diarrhea | Biotech Hunter | Biotech Hunter